Biogen joins CTTV
Pioneering target validation collaboration expands to accelerate drug discovery research.
CONNECTIONSLAB MATTERS2016
connectionslab-matters
Target Validation platform launches
Identifying evidence-based relationships between drug targets and diseases.
CONNECTIONSLAB MATTERS2015
connectionslab-matters
Jeffrey Barrett to lead CTTV
Jeffrey Barrett appointed Director of CTTV, the GSK, EMBL-EBI and Sanger Institute partnership.
LAB MATTERS2015
lab-matters
On target
A new EMBL-EBI biomedical initiative works to determine the best target proteins for new drugs.
CONNECTIONSLAB MATTERS2014
connectionslab-matters
Where do you start when developing a new medicine?
A pioneering public-private research initiative between GSK, the European Bioinformatics Institute (EMBL-EBI) and the Wellcome Trust Sanger Institute is to harness the power of ‘big data’ and genome sequencing to improve the success rate for discovering new medicines. The new Centre for…
CONNECTIONSLAB MATTERS2014
connectionslab-matters
No results found